Background: Long-term effects of laparoscopic electrocautery of the ovaries are unknown. To study the long-term effects of laparoscopic electrocautery of the ovaries and gonadotrophins, we followed women with clomiphene-resistant polycystic ovary syndrome (PCOS) randomly allocated to one of these treatments until 812 years after their initial treatment. Methods: Between February 1998 and October 2001 168 women with clomiphene citrate-resistant PCOS were included in a randomized controlled trial comparing an electrocautery strategy to a strategy starting with rFSH. In 2009 these women were contacted about their reproductive outcome and menstrual cycle regularity. Analysis was by intention-to-treat. We compared time to conception resulting in live birth, subsequent pregnancies, ectopic and multiple pregnancies, menopause, as well as minimal and maximal menstrual cycle length. Results: After 812 years, the cumulative proportion of women with a first child was 86 in women who had been allocated to electrocautery versus 81 in women who had been allocated to immediate rFSH [relative ratio (RR): 1.1; 95 confidence interval (CI): 0.921.2]. Treatment with electrocautery resulted in a significantly lower need for stimulated cycles to reach a live birth; 53 after electrocautery versus 76 after rFSH (RR: 0.69; 95 CI: 0.550.88).The cumulative proportion of women with a second child was 61 after electrocautery versus 46 after immediate rFSH (RR: 1.4; 95 CI: 1.001.9). Overall, there were 7 twins out of 134 deliveries (5) after electrocautery versus 10 twins out of 124 deliveries (8) in the rFSH group (RR: 0.65; 95 CI: 0.251.6). Fifty-four per cent of the women allocated to electrocautery had a regular menstrual cycle 812 years after randomization versus 36 in those allocated to rFSH (RR: 1.5; 95 CI: 0.872.6).CONCLUSIONIn women with clomiphene-resistant PCOS, laparoscopic electrocautery of the ovaries is as effective as ovulation induction with FSH treatment in terms of live births, but reduces the need for ovulation induction or ART in a significantly higher proportion of women and increases the chance for a second child. Clinicians may use these data when informing clomiphene-resistant anovulatory women about treatment options.
|Number of pages||6|
|Publication status||Published - Jul 2011|
- clomiphene citrate
- follicle-stimulating hormone
- ovulation induction